
|Articles|October 19, 2007
Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
Advertisement
A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Rise in Supplement Use Calls for Pharmacist-Led Counseling, Education | NCPA 2025
2
Pneumococcal Diseases Require Constant Vaccine Development | NCPA 2025
3
The Variety of Migraine Treatment Options Opens the Door for Pharmacy Services | NCPA 2025
4
Why Pharmacists Need to Put More Emphasis on Supplement Education | NCPA 2025
5